Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

SciClone to commercialize clevidipine and bivalirudin in China

Dec. 23, 2014

Johns Hopkins University patents novel aptamers for sickle cell anemia

Dec. 22, 2014

NESP approved for anemia with myelodysplastic syndromes in Japan

Dec. 22, 2014

Bayer files BLA for BAY-81-8973 for treatment of hemophilia A

Dec. 19, 2014

Promising data presented on novel drug for the treatment of pyruvate kinase deficiency

Dec. 19, 2014

CSL Behring submits BLA to FDA for rIX-FP

Dec. 17, 2014

New study evaluates dabigatran etexilate to prevent recurrent embolic stroke of undetermined source

Dec. 16, 2014

Pieris begins phase I study of Anticalin to treat anemia

Dec. 12, 2014

Spark Therapeutics and Pfizer establish gene therapy collaboration in hemophilia B

Dec. 11, 2014

ONO-8610539: a potent coagulation factor XIa inhibitor for the treatment of DVT

Dec. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...